CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Open-market sale Director sold 2,084 shares at $549.00 ($1,144,116)
- 4 Open-market sale President and Chief Scientific sold 80,000 shares at an average $538.90 ($43,112,141)
- 4 Open-market sale Director sold 100 shares at an average $524.76 ($52,476)
- 4 Open-market sale Director sold 1,700 shares at $525.00 ($892,500)
- 4 Open-market sale Director sold 1,930 shares at $525.00 ($1,013,250)
- 4 Open-market sale EVP Commercial sold 1,000 shares at $511.65 ($511,650)
- 4 Open-market sale EVP Research and Development sold 17,521 shares at an average $519.46 ($9,101,460)
- 4 Open-market sale EVP Commercial sold 1,000 shares at $495.63 ($495,630)
- 4 Shares withheld for taxes Director gave up 137,998 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 100 shares at an average $506.92 ($50,692)
- 4 Open-market sale Director sold 2,480 shares at $554.32 ($1,374,714)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
- 4 Grant or award Director acquired 248 shares (grant or award)
Page 22 of 77 · 1,533 filings